Literature DB >> 21580616

3-(2,4-Dichloro-phen-yl)-5-methyl-1,2,4-oxadiazole.

Hoong-Kun Fun, Mohd Mustaqim Rosli, Sankappa Rai, Arun M Isloor, Prakash Shetty.   

Abstract

In the title compound, C(9)H(6)Cl(2)N(2)O, the dihedral angle between the oxadiazole and benzene rings is 1.7 (2)°. In the crystal, the mol-ecules are linked into chains along the b axis by short inter-molecular Cl⋯O contacts [3.019 (3) Å].

Entities:  

Year:  2010        PMID: 21580616      PMCID: PMC2983957          DOI: 10.1107/S1600536810007932

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general background and the biological activity of oxa­diazole compounds, see: Andersen et al. (1994 ▶); Clitherow et al. (1996 ▶); Showell et al. (1991 ▶); Swain et al. (1991 ▶); Watjen et al. (1989 ▶). For a related structure, see: Wang et al. (2006 ▶). For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986 ▶).

Experimental

Crystal data

C9H6Cl2N2O M = 229.06 Monoclinic, a = 3.8252 (7) Å b = 21.678 (4) Å c = 11.0833 (19) Å β = 92.421 (4)° V = 918.3 (3) Å3 Z = 4 Mo Kα radiation μ = 0.67 mm−1 T = 100 K 0.28 × 0.17 × 0.11 mm

Data collection

Bruker SMART APEXII CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2005 ▶) T min = 0.833, T max = 0.929 7920 measured reflections 2076 independent reflections 1709 reflections with I > 2σ(I) R int = 0.048

Refinement

R[F 2 > 2σ(F 2)] = 0.056 wR(F 2) = 0.155 S = 1.20 2076 reflections 128 parameters H-atom parameters constrained Δρmax = 0.72 e Å−3 Δρmin = −0.56 e Å−3 Data collection: APEX2 (Bruker, 2005 ▶); cell refinement: SAINT (Bruker, 2005 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536810007932/ci5045sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810007932/ci5045Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C9H6Cl2N2OF(000) = 464
Mr = 229.06Dx = 1.657 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 3719 reflections
a = 3.8252 (7) Åθ = 2.6–31.1°
b = 21.678 (4) ŵ = 0.67 mm1
c = 11.0833 (19) ÅT = 100 K
β = 92.421 (4)°Block, colourless
V = 918.3 (3) Å30.28 × 0.17 × 0.11 mm
Z = 4
Bruker SMART APEXII CCD area-detector diffractometer2076 independent reflections
Radiation source: fine-focus sealed tube1709 reflections with I > 2σ(I)
graphiteRint = 0.048
φ and ω scansθmax = 27.5°, θmin = 1.9°
Absorption correction: multi-scan (SADABS; Bruker, 2005)h = −4→4
Tmin = 0.833, Tmax = 0.929k = −26→28
7920 measured reflectionsl = −13→14
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.056Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.155H-atom parameters constrained
S = 1.20w = 1/[σ2(Fo2) + (0.0428P)2 + 4.0517P] where P = (Fo2 + 2Fc2)/3
2076 reflections(Δ/σ)max = 0.001
128 parametersΔρmax = 0.72 e Å3
0 restraintsΔρmin = −0.56 e Å3
Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl10.2530 (2)0.40084 (4)0.92173 (8)0.0163 (2)
Cl20.1238 (3)0.63730 (4)0.78985 (9)0.0185 (3)
O1−0.2054 (8)0.27327 (13)0.6574 (3)0.0220 (7)
N1−0.3467 (8)0.35961 (15)0.5636 (3)0.0158 (7)
N2−0.0709 (10)0.32171 (16)0.7322 (3)0.0194 (7)
C1−0.3637 (11)0.30045 (18)0.5605 (4)0.0173 (8)
C2−0.1651 (10)0.37119 (18)0.6715 (3)0.0140 (8)
C3−0.0869 (9)0.43519 (17)0.7088 (3)0.0124 (7)
C40.0928 (10)0.45392 (18)0.8165 (3)0.0137 (8)
C50.1523 (9)0.51553 (18)0.8418 (4)0.0136 (7)
H5A0.26840.52720.91360.016*
C60.0369 (10)0.56000 (17)0.7588 (3)0.0127 (7)
C7−0.1429 (10)0.54398 (18)0.6533 (4)0.0151 (8)
H7A−0.22400.57400.59900.018*
C8−0.1993 (10)0.48214 (18)0.6303 (4)0.0153 (8)
H8A−0.31860.47120.55860.018*
C9−0.5226 (12)0.2592 (2)0.4666 (4)0.0237 (9)
H9A−0.64280.28350.40550.036*
H9B−0.68560.23190.50280.036*
H9C−0.34220.23540.43080.036*
U11U22U33U12U13U23
Cl10.0168 (5)0.0182 (5)0.0138 (5)0.0028 (3)−0.0011 (3)0.0023 (4)
Cl20.0197 (5)0.0140 (4)0.0219 (5)−0.0024 (3)0.0025 (4)−0.0017 (4)
O10.0309 (17)0.0139 (14)0.0213 (15)−0.0017 (12)0.0017 (12)−0.0018 (12)
N10.0130 (15)0.0175 (16)0.0172 (17)0.0000 (12)0.0018 (12)−0.0022 (13)
N20.0257 (19)0.0147 (16)0.0178 (18)−0.0002 (14)0.0018 (14)−0.0032 (13)
C10.0148 (19)0.0194 (19)0.018 (2)0.0000 (15)0.0051 (15)−0.0007 (15)
C20.0103 (17)0.0185 (19)0.0138 (18)0.0022 (14)0.0081 (14)0.0000 (14)
C30.0078 (17)0.0152 (18)0.0150 (18)0.0009 (13)0.0080 (14)−0.0011 (14)
C40.0126 (18)0.0171 (19)0.0119 (19)0.0043 (13)0.0054 (14)0.0016 (14)
C50.0070 (16)0.0208 (19)0.0132 (18)0.0017 (14)0.0022 (13)−0.0021 (15)
C60.0106 (17)0.0134 (17)0.0144 (18)−0.0008 (13)0.0033 (13)−0.0027 (14)
C70.0106 (18)0.0174 (19)0.0177 (19)0.0033 (14)0.0056 (14)0.0033 (15)
C80.0114 (17)0.0181 (19)0.017 (2)0.0005 (14)0.0055 (14)0.0004 (15)
C90.025 (2)0.018 (2)0.029 (2)−0.0030 (16)0.0041 (18)−0.0072 (17)
Cl1—C41.732 (4)C4—C51.382 (5)
Cl2—C61.740 (4)C5—C61.391 (5)
O1—C11.346 (5)C5—H5A0.93
O1—N21.421 (4)C6—C71.376 (5)
N1—C11.285 (5)C7—C81.380 (6)
N1—C21.381 (5)C7—H7A0.93
N2—C21.308 (5)C8—H8A0.93
C1—C91.483 (6)C9—H9A0.96
C2—C31.475 (5)C9—H9B0.96
C3—C81.396 (5)C9—H9C0.96
C3—C41.411 (5)
C1—O1—N2106.4 (3)C6—C5—H5A120.3
C1—N1—C2103.2 (3)C7—C6—C5121.3 (4)
C2—N2—O1102.8 (3)C7—C6—Cl2119.7 (3)
N1—C1—O1113.3 (4)C5—C6—Cl2119.0 (3)
N1—C1—C9129.8 (4)C6—C7—C8118.1 (4)
O1—C1—C9116.9 (4)C6—C7—H7A121.0
N2—C2—N1114.4 (4)C8—C7—H7A121.0
N2—C2—C3125.4 (4)C7—C8—C3123.5 (4)
N1—C2—C3120.2 (3)C7—C8—H8A118.3
C8—C3—C4116.4 (3)C3—C8—H8A118.3
C8—C3—C2117.2 (3)C1—C9—H9A109.5
C4—C3—C2126.4 (3)C1—C9—H9B109.5
C5—C4—C3121.3 (3)H9A—C9—H9B109.5
C5—C4—Cl1117.1 (3)C1—C9—H9C109.5
C3—C4—Cl1121.6 (3)H9A—C9—H9C109.5
C4—C5—C6119.4 (3)H9B—C9—H9C109.5
C4—C5—H5A120.3
C1—O1—N2—C20.1 (4)C8—C3—C4—C50.0 (5)
C2—N1—C1—O1−0.4 (5)C2—C3—C4—C5179.8 (3)
C2—N1—C1—C9−179.1 (4)C8—C3—C4—Cl1−179.1 (3)
N2—O1—C1—N10.2 (5)C2—C3—C4—Cl10.6 (5)
N2—O1—C1—C9179.1 (3)C3—C4—C5—C6−0.8 (6)
O1—N2—C2—N1−0.4 (4)Cl1—C4—C5—C6178.4 (3)
O1—N2—C2—C3−179.3 (3)C4—C5—C6—C71.6 (6)
C1—N1—C2—N20.5 (5)C4—C5—C6—Cl2−178.3 (3)
C1—N1—C2—C3179.5 (3)C5—C6—C7—C8−1.5 (6)
N2—C2—C3—C8178.0 (4)Cl2—C6—C7—C8178.4 (3)
N1—C2—C3—C8−0.8 (5)C6—C7—C8—C30.7 (6)
N2—C2—C3—C4−1.8 (6)C4—C3—C8—C70.1 (6)
N1—C2—C3—C4179.4 (4)C2—C3—C8—C7−179.7 (4)
  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Tetrahydropyridyloxadiazoles: semirigid muscarinic ligands.

Authors:  G A Showell; T L Gibbons; C O Kneen; A M MacLeod; K Merchant; J Saunders; S B Freedman; S Patel; R Baker
Journal:  J Med Chem       Date:  1991-03       Impact factor: 7.446

3.  Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines.

Authors:  F Watjen; R Baker; M Engelstoff; R Herbert; A MacLeod; A Knight; K Merchant; J Moseley; J Saunders; C J Swain
Journal:  J Med Chem       Date:  1989-10       Impact factor: 7.446

4.  Novel 5-HT3 antagonists. Indole oxadiazoles.

Authors:  C J Swain; R Baker; C Kneen; J Moseley; J Saunders; E M Seward; G Stevenson; M Beer; J Stanton; K Watling
Journal:  J Med Chem       Date:  1991-01       Impact factor: 7.446

5.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  5 in total
  1 in total

1.  5-(2,4-Dichloro-phen-yl)-3-(4-nitro-phen-yl)-1,2,4-oxadiazole.

Authors:  Hoong-Kun Fun; Mohd Mustaqim Rosli; Sankappa Rai; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.